There is ample evidence suggesting that calcium/calmodulin-dependent protein kinase II alpha (CaMK2A) may play an important role in the pathophysiology of Alzheimer’s disease (AD). This evidence concerns the gene CAMK2A and early-onset autosomal dominant Alzheimer disease.